MedPacto Inc
235980
Company Profile
Business description
MedPacto Inc is a drug discovery and development company based in South Korea. It is engaged in developing anticancer drugs and medicines which focuses on therapeutics targeting cancer and autoimmune diseases. Its products are in pipeline.
Contact
92 Myeongdal -ro
Seocho-gu, Borim Building
Seoul
KORT: +82 269380200
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
56
Stocks News & Analysis
stocks
The World Cup stock you’ve never heard of
This ASX stock is kicking goals at the FIFA World Cup.
stocks
Chart of the Week: Can WiseTech shares finally bounce back?
Market concerns over governance and AI fears have left shares trading well below the fair value.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,003.70 | 34.90 | 0.39% |
| CAC 40 | 8,333.35 | 6.73 | 0.08% |
| DAX 40 | 25,120.88 | 2.61 | 0.01% |
| Dow JONES (US) | 52,566.02 | 78.61 | 0.15% |
| FTSE 100 | 10,510.77 | 38.32 | 0.37% |
| HKSE | 24,175.12 | 144.94 | 0.60% |
| NASDAQ | 26,182.03 | 24.87 | -0.09% |
| Nikkei 225 | 68,557.73 | 813.88 | 1.20% |
| NZX 50 Index | 13,785.67 | 120.49 | 0.88% |
| S&P 500 | 7,552.73 | 9.09 | 0.12% |
| S&P/ASX 200 | 8,806.00 | 38.20 | 0.44% |
| SSE Composite Index | 3,996.16 | 40.43 | -1.00% |